I now have comprehensive, detailed content from multiple authoritative sources. Here is a complete, well-organized answer:
Management of Raised Intracranial Pressure (ICP)
Normal Values & Treatment Thresholds
- Normal ICP: 5-15 mmHg
- Treatment threshold: >20-22 mmHg (ACS TQIP / Brain Trauma Foundation guidelines)
- Cerebral Perfusion Pressure (CPP) = MAP - ICP; target 60-70 mmHg
Monitoring
Indications for ICP monitoring:
- GCS 3-8 with abnormal CT scan
- GCS 3-8 with normal CT but 2 of: age >40, posturing, systolic BP <90 mmHg
- Before urgent extracranial surgery in comatose TBI patients
Devices:
- External ventricular drain (EVD) / ventriculostomy - gold standard; also allows CSF drainage therapeutically
- Intraparenchymal fiberoptic monitor - simpler to insert, cannot drain CSF
- Subdural/epidural monitors - less accurate, less used
Note: The BEST:TRIP randomized trial found that clinical observation + CT imaging performs comparably to ICP-monitor-guided management - but monitoring remains standard in most ICUs for guiding therapy.
Three-Tier Management Approach (ACS TQIP / SIBICC)
Tier 1 - First-Line Measures (for ICP >20-22 mmHg)
| Intervention | Details |
|---|
| Head positioning | Head of bed at 30°, neutral head position; ensure cervical collars don't obstruct jugular venous outflow |
| Analgesia & Sedation | Fentanyl 25-50 mcg PRN; propofol (preferred - reduces CMRO₂, O₂ demand, CBF; clears rapidly for neuro exam); alternative: dexmedetomidine (avoids respiratory drive suppression) |
| CSF drainage | Intermittent EVD/ventriculostomy drainage - immediate ICP reduction |
| Avoid precipitants | Treat fever, prevent pain/agitation/coughing, correct hypoxia, avoid hypotonic fluids (5% dextrose, 0.45% saline) |
| Fluids | Normal saline is ideal; lactated Ringer's permissible; avoid albumin in TBI (SAFE study: worse outcomes) |
| Intubation / ventilation | Avoid hypoxia (SpO₂ <90%) and hypercarbia; target PaCO₂ 35-45 mmHg |
Tier 2 - Escalation (ICP persistently >22 mmHg despite Tier 1)
Hyperosmolar Therapy - creates an osmotic gradient, draws water out of brain across intact blood-brain barrier, also reduces blood viscosity and cerebral blood volume rapidly:
| Agent | Dosing | Limits | Notes |
|---|
| Mannitol 20% | 0.25-1 g/kg IV q3-6h | Hold if serum osmolality >315-320 mOsm/L | Potent diuretic; preferred in fluid overload; risk of renal failure with >200g/day |
| Hypertonic saline 3% | 30-50 mL/hr infusion or 150 mL boluses | Hold if Na >155-160 mEq/L | Expands intravascular volume; use in hypovolemia/poor cardiac reserve; requires central line at >3% concentrations |
| HTS 7.5% | 75 mL boluses | Na <160 mEq/L | Central line required |
| HTS 23.4% | 30 mL boluses | Na <160 mEq/L | Central line required; fastest acting |
No definitive evidence favors mannitol over hypertonic saline. Choose based on volume status and side-effect profile.
Hyperventilation (short-term bridge):
- Target PaCO₂ 30-35 mmHg
- Mechanism: cerebral vasoconstriction → reduced cerebral blood volume → ICP falls within minutes
- Duration limited: CSF pH equilibrates within 4-6 hours as choroid plexus elaborates ammonium ions → effect wanes
- Risk: cerebral ischemia from over-vasoconstriction; only use as temporizing measure for herniation
Neuromuscular blockade:
- Give a test dose; if successful in reducing ICP, move to continuous infusion (considered Tier 3)
Cerebral autoregulation assessment - guides CPP targets
Tier 3 - Refractory Intracranial Hypertension
| Intervention | Details |
|---|
| Barbiturate coma | Pentobarbital: 10 mg/kg loading dose over 30 min, then 1-4 mg/kg/h; titrate to EEG burst suppression; reduces CMRO₂ and CBF; often requires vasopressors for hypotension |
| Decompressive craniectomy | Bilateral or hemicraniectomy; allows brain to expand outward; DECRA and RESCUEicp trials showed ICP reduction but mixed functional outcome data |
| Continuous NMB | If test dose in Tier 2 was effective |
| Hypothermia | Used in some centres; evidence remains mixed |
Special Situations
Herniation Syndromes (Immediate Threat)
- Hyperventilate immediately (ETCO₂ target 30-35 mmHg) as bridge
- Hyperosmolar bolus (mannitol or 23.4% HTS 30 mL)
- Emergency neurosurgical referral
- Surgical evacuation for EDH >30 mL, SDH >1 cm or with midline shift + neurological deterioration
Prehospital Setting
- Avoid prophylactic hyperventilation; target ETCO₂ 35-45 mmHg
- Exception: GCS <9 with Cushing's triad (hypertension + bradycardia + irregular breathing), posturing, or fixed dilated pupils → target ETCO₂ 30-35 mmHg
- Do NOT give hyperosmolar agents prophylactically prehospital
Vasogenic Edema (Tumor/Abscess)
- Dexamethasone (corticosteroids) highly effective for perilesional vasogenic edema around tumors; not indicated for traumatic brain injury
Acute Ischemic Stroke with Raised ICP
- Decompressive hemicraniectomy within 48h in malignant MCA infarction (<60 years) is life-saving
What to Avoid
- Hypotonic fluids (5% dextrose, 0.45% NaCl) - worsen cerebral edema
- Albumin in TBI (SAFE study: harmful)
- Routine prophylactic hyperventilation - causes ischemia
- Glucocorticoids in TBI - CRASH trial showed increased mortality
Summary Algorithm
ICP > 20-22 mmHg
|
TIER 1: HOB 30°, analgesia/propofol sedation, EVD drainage, normothermia, euvolemia, normoxia
|
Still elevated?
|
TIER 2: Hyperosmolar therapy (mannitol or HTS), short hyperventilation, NMB test dose
|
Still elevated?
|
TIER 3: Barbiturate coma + EEG, decompressive craniectomy, continuous NMB
Sources:
- Adams & Victor's Principles of Neurology, 12th Ed., Ch. 34 - "Management of Raised Intracranial Pressure"
- Sabiston Textbook of Surgery (2024), Ch. 41 - Three-tier ACS TQIP protocol
- Rosen's Emergency Medicine - Concepts and Clinical Practice
Recent evidence note: A 2025 meta-analysis (PMID 40449835) examined timing of ICP monitoring in TBI - early monitoring appears associated with better outcomes, consistent with current guidelines.